Trial Profile
Facts Study (Fakten-studie): Non-interventional Study to Investigate Whether Information Provided to Patients Influences Satisfaction With Toviaz Therapy As Perceived by the Patient.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 Mar 2013
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms FACTS
- Sponsors Pfizer
- 20 Jul 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Feb 2012 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.